All Videos

E. James Song, MD, FAAD, presents a case of a 58-year-old patient with location-specific mild-to-moderate plaque psoriasis.

Panelists discuss how to optimize plaque psoriasis treatment in a 32-year-old man, with a specific focus on addressing genital plaques to enhance patient comfort and improve overall treatment outcomes.

Panelists discuss how to develop tailored treatment approaches for a 34-year-old African American woman with plaque psoriasis, focusing on exploring nonsystemic options that consider her specific demographic and clinical profile.

Panelists discuss how to effectively manage plaque psoriasis in a 55-year-old man by evaluating and potentially combining topical treatments with systemic therapies for optimal disease control.

Panelists discuss how their clinical experiences with topical ruxolitinib are shaping new treatment paradigms for vitiligo, while also addressing challenges related to medication access.

Panelists discuss how the two approved PDE4 inhibitors for pediatric plaque psoriasis differ in their systemic treatments, highlighting key differences in efficacy, safety profiles, and patient considerations for optimal use.

Panelists discuss how novel treatment mechanisms, efficacy assessments, and improved patient engagement strategies are shaping the evolving landscape of vitiligo management.

Panelists discuss how phosphodiesterase-4 (PDE4) inhibitors, with their ability to modulate inflammatory pathways, hold promise as therapeutic targets for immune-mediated diseases like pediatric plaque psoriasis, offering unique benefits by potentially reducing inflammation with a favorable safety profile for pediatric patients.

A dermatologist provides clinical insights on navigating dose escalation and insurance barriers for patients receiving treatment for plaque psoriasis.

Continuing discussion on a case of a 45-year-old patient with plaque psoriasis, E. James Song, MD, FAAD, discusses management strategies for patients with mild-to-moderate plaque psoriasis.

Brad Glick, DO, MPH, discusses common challenges clinicians may encounter with photodynamic therapy (PDT) and offers resolution strategies, while also sharing insights on the skin conditions and patient populations where PDT has proven to be a successful treatment option.

Brad Glick, DO, MPH, discusses how to effectively introduce photodynamic therapy (PDT) into a dermatology clinic by outlining necessary equipment and setup, providing guidance on essential patient discussions for treatment introduction, and sharing strategies to ensure treatment efficacy while prioritizing patient safety and satisfaction.

Brad Glick, DO, MPH, discusses how photodynamic therapy (PDT) serves as an effective treatment for various skin conditions, highlighting the specific patient populations that are most likely to benefit from this innovative approach.

Panelists discuss how to address treatment challenges and manage site-specific concerns in vitiligo patients, drawing on expert insights and clinical experience.

Panelists discuss how limited treatment options, safety concerns, adherence issues, and the lack of long-term data pose significant challenges in effectively managing pediatric vs adult plaque psoriasis, highlighting the need for more research and tailored approaches for this patient population.

Panelists discuss how phototherapy, combination treatments, and patient-centered strategies can be utilized to enhance quality of life for individuals with vitiligo.

Karan Lal, DO, and Helen T Shin, MD, discuss how early diagnosis of pediatric plaque psoriasis significantly improves management strategies and enhances long-term outcomes by allowing for timely intervention and personalized treatment plans.

Focusing on treatment paradigms in plaque psoriasis, E. James Song, MD, FAAD, provides insights on phosphodiesterase inhibitors 4 (PDE-4) and their role in the therapeutic landscape.

E. James Song, MD, FAAD, presents the case of a 45-year-old woman with plaque psoriasis who lives in a rural area, introducing a discussion on clinical telemedicine practices.

Panelists discuss how red light therapy has emerged as a versatile, noninvasive treatment in aesthetic dermatology, offering benefits such as collagen stimulation and skin rejuvenation while comparing favorably with other cosmetic treatments in terms of minimal adverse effects and high patient satisfaction rates.

Panelists discuss how red light therapy accelerates wound healing by stimulating cellular energy production, increasing blood flow, reducing inflammation, and promoting collagen synthesis, leading to faster tissue repair and regeneration in various clinical scenarios.

Aaron Farberg, MD, discusses how red light therapy utilizes specific wavelengths of light to penetrate skin cells, stimulating mitochondrial function, potentially leading to various therapeutic effects such as reduced inflammation and improved tissue repair.

Pearl E. Grimes, MD, discusses the evolving treatment paradigm for vitiligo, highlighting the role of FDA-approved topical ruxolitinib and its impact on management strategies.

Pearl E. Grimes, MD, explores managing long-standing vitiligo with facial involvement, focusing on over-the-counter solutions, repigmentation strategies, and relapse prevention techniques.

Pearl E. Grimes, MD, discusses strategies for optimizing vitiligo stabilization and repigmentation through combination therapies, emphasizing long-term maintenance, treatment modalities, and the use of topical agents like tacrolimus and ruxolitinib cream.

Pearl E. Grimes, MD, provides case-based insights on managing long-standing vitiligo with extensive depigmentation and atopic comorbidities, focusing on treatment history, comorbid conditions, and the impact on quality of life.

Panelists discuss how to improve treatment adherence, incorporate adjunctive therapies, and simplify complex regimens for patients with vitiligo through case-based analysis.

Panelists discuss how vitiligo treatment delays, psychosocial effects, and emerging therapies impact standard of care for patients through case-based analysis.

Panelists discuss how managing psoriasis in children poses distinct challenges compared to adult patients.